IGF-1 LR3 1mg

IGF-1-LR3 is a breakthrough peptide that has shown great results without many of the side effects or risks of other more commonly prescribed fat loss medications. Its long half life of close to a day has made it a preferred variant by a majority ofpatients and physicians because site injections are never necessary. IGF-1 LR3 inhibits the movement of glucose into the body’s cells which facilitates fat burning and the use of fat in the body to produce energy. Its effects last most of the day and have made it a preferred variant by most patients and physicians. When IGF-1 LR3 is active in the body, it functions differently in different types of tissues. For instance, in muscle tissue, it makes the muscle more sensitive to insulin’s effects, such as a reduction in fat storage.

Product Specifications:

• Purity: ≥99% (HPLC Verified)
• Form: Lyophilized Powder
• Unit Size: 10mg per vial
• Storage: Store at -20°C or lower
• Usage: For in vitro research use only

Research Applications:

Protein synthesis in the body

Fat storage is channeled for energy production, which results in a noticeable fat loss.

Positive effects on metabolism, increasing lean body mass and decreasing fat

Increase in regenerative properties of the body’s nerve tissues

Upregulates antioxidant benefit and ligament strength

Boosts hyperplasia in muscle cells, which leads to fuller muscle tissues.

Improved cognitive function

IGF-1 in high doses can cause hypoglycemia, but it is not as severe as that caused by insulin. This is the most common side effect. It is highly debated that IGF-1 can increase the size of a tumor in cancer patients. Even though this factor might be true in patients with existing cancer cases, IGF-1 does not cause cancer. In fact, the human body requires IGF-1 to regulate heart functions, brain cell stimulation and to improve the functioning of the nervous system.

Disclaimer: Ipamorelin 10mg is intended exclusively for in vitro research. It is not approved for human or animal use.